Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast?

Diabetes Research and Clinical Practice

Volumn 83, Issue 1, 2009, Pages

  Bhansali, Anil ^a   Venkatesh, S ^a   Dutta, Pinaki ^a   Dhillon, M S ^a   Das, Sambit ^a   Agrawal, Aditya ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Neuropathic plantar ulcers; rh PDGF; Total contact cast

Indexed keywords

PLATELET DERIVED GROWTH FACTOR BB; PLERMIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAST APPLICATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE DURATION; DRUG EFFICACY; FEMALE; GEL; HEALING; HUMAN; HUMAN TISSUE; INCIDENCE; MALE; PLANTAR ULCER; ULCER; WOUND CARE;

ADULT; AGED; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; RECOMBINANT PROTEINS; TREATMENT OUTCOME; WOUND HEALING;

EID: 57949103536     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.10.005     Document Type: Article

References (13)

1. Das A.K., and Joshi S.R. Put Feet First: Prevent Amputations"-diabetes and feet. J. Assoc. Physicians Ind. 53 (2005) 929-930
2. Cevera J.J., Bolton L.L., and Kerstein M.D. Options for diabetic patients with chronic heel ulcers. J. Diabe. Compli. 11 (1997) 358-366
3. American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, MA. Diabetes Care 22 (1999) 1354-1360.
4. Reiber G.E., Bokyo E.J., and Smith D.G. Lower extremity foot ulcers and amputations in diabetes. In: Harris M.I., Cowie C.C., and Reiber G. (Eds). Diabetes in America (1995), US Government Printing Office, Washington, DC 409-428
5. Armstrong D.G., and Lavery L.A. Evidence-based options for off-loading diabetic wounds. Clin. Pediatr. Med. Surg. 15 (1998) 95-104
6. Kristy C.P., Lynch A.B., and Lynch S.E. Role of growth factors in cutaneous wound healing: a review. Crit. Rev. Oral Biol. Med. 4 (1993) 729-760
7. Greenhalgh D.G. The role of growth factors in wound healing. J. Trauma. 41 (1996) 159-167
8. Robson M.C. The role of growth factors in the healing of chronic wounds. Wound Repair Regen. 5 (1997) 12-17
9. Robson M.C. Exogenous growth factor application effect on human wound healing. Prog. Dermatol. 30 (1996) 1-7
10. Weiman T.J., Smiell J.M., and Yachin S.U. Efficacy and safety of a topical gel formulation of rh-PDGF-BB/becaplermin in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 21 (1998) 822-827
11. Steed D.L., and Diabetic ulcer study group. Clinical evaluation of rh-PDGF for the treatment of lower extremity diabetic ulcers. J. Vasc. Sur. 21 (1995) 71-78
12. Hardikar J.V. Efficacy of recombinant human platelet derived growth factor (rhPDGF) based gel in diabetic foot ulcers: a randomized, multicenter, double-blind, placebo-controlled study in India. Wounds 17 (2005) 141-152
13. U.S. Food and Drug Administration: Update of Safety Record Follow-up to the March 27, 2008, Communication about the ongoing safety review of Regranex. Online at .